Clinical chemistry and laboratory medicine最新文献

筛选
英文 中文
IVDCheckR - simplifying documentation for laboratory developed tests according to IVDR requirements by introducing a new digital tool. IVDCheckR - 通过引入一种新的数字工具,简化了根据 IVDR 要求进行的实验室开发测试的文档记录。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-26 DOI: 10.1515/cclm-2024-0477
Yadwinder Kaur, Daniel Rosenkranz, Anna Bloemer, Ozan Aykurt, Gunnar Brandhorst, Folker Spitzenberger, Astrid Petersmann
{"title":"IVDCheckR - simplifying documentation for laboratory developed tests according to IVDR requirements by introducing a new digital tool.","authors":"Yadwinder Kaur, Daniel Rosenkranz, Anna Bloemer, Ozan Aykurt, Gunnar Brandhorst, Folker Spitzenberger, Astrid Petersmann","doi":"10.1515/cclm-2024-0477","DOIUrl":"https://doi.org/10.1515/cclm-2024-0477","url":null,"abstract":"<p><strong>Objectives: </strong>A recent challenge for clinical laboratories is the lack of clear guidelines for handling significant modifications of CE-marked assays. The modifications may involve, for example, extending measurement intervals, changing dilution procedures or using non-validated sample materials. The challenge arises due to the amended Regulation (EU) 2017/746 on <i>in vitro</i> diagnostic medical devices (IVDR), which is now poised for implementation, despite the extended transition periods. The IVDR application imposes challenges not only for diagnostic companies but also for clinical laboratories when using laboratory developed tests (LDTs), often referred to as in-house assays. In this context, a coherent and meticulously structured LDT documentation is highly beneficial. While laboratories are obliged to meet the IVDR requirements, the absence of a streamlined framework or guideline hampers the ability to gain a comprehensive overview on the requirements and possible options for their fulfilment.</p><p><strong>Methods: </strong>To address this issue, we introduce a web based digital tool powered by an R Shiny web application. This tool facilitates a seamless implementation of IVDR requirements for LDTs across diverse laboratory environments in terms of their transparency and validity. Our approach focuses on adequate handling of significant modifications of CE-marked <i>in vitro</i> diagnostic medical devices (IVD).</p><p><strong>Results: </strong>IVDRCheckR is an open-source tool that is easily accessible and free from system dependencies. The tool promotes a seamless process and a guide to enhance transparency, reliability, and validity of laboratory examination results based on LDTs. Additionally, the tool further provides modules for evaluating quality control data and quantitative method comparison data.</p><p><strong>Conclusions: </strong>Our Shiny web application-based platform is a digitised, user-friendly tool that simplifies the documentation for LDTs according to IVDR requirements with special emphasis on solutions for handling modifications to CE-marked assays.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reference intervals of 24 trace elements in blood, plasma and erythrocytes for the Slovenian adult population. 斯洛文尼亚成年人血液、血浆和红细胞中 24 种微量元素的参考区间。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-26 DOI: 10.1515/cclm-2024-0868
Alenka France Štiglic, Ingrid Falnoga, Alenka Sešek Briški, Marko Žavbi, Joško Osredkar, Milan Skitek, Janja Marc
{"title":"Reference intervals of 24 trace elements in blood, plasma and erythrocytes for the Slovenian adult population.","authors":"Alenka France Štiglic, Ingrid Falnoga, Alenka Sešek Briški, Marko Žavbi, Joško Osredkar, Milan Skitek, Janja Marc","doi":"10.1515/cclm-2024-0868","DOIUrl":"https://doi.org/10.1515/cclm-2024-0868","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capillary blood parameters are gestational age, birthweight, delivery mode and gender dependent in healthy preterm and term infants. 健康早产儿和足月儿的毛细血管血液参数与胎龄、出生体重、分娩方式和性别有关。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-23 DOI: 10.1515/cclm-2024-0821
Marika Perrotta, Ebe D'Adamo, Chiara Strozzi, Claudia D'Egidio, Francesca Del Rosso, Antonio Maconi, Simonetta Picone, Giustina Giardinelli, Laura Cepelli, Ilenia Cicolini, Mariangela Conte, Mariangela Bellinaso, Rossana Negri, Francesca Gazzolo, Maurizio Cassinari, Laura Abella, Ali Saber Abdelhameed, Rocco Mangifesta, Diego Gazzolo
{"title":"Capillary blood parameters are gestational age, birthweight, delivery mode and gender dependent in healthy preterm and term infants.","authors":"Marika Perrotta, Ebe D'Adamo, Chiara Strozzi, Claudia D'Egidio, Francesca Del Rosso, Antonio Maconi, Simonetta Picone, Giustina Giardinelli, Laura Cepelli, Ilenia Cicolini, Mariangela Conte, Mariangela Bellinaso, Rossana Negri, Francesca Gazzolo, Maurizio Cassinari, Laura Abella, Ali Saber Abdelhameed, Rocco Mangifesta, Diego Gazzolo","doi":"10.1515/cclm-2024-0821","DOIUrl":"https://doi.org/10.1515/cclm-2024-0821","url":null,"abstract":"<p><strong>Objectives: </strong>The measurement of blood pH and gas analytes (BPGA), soon after birth, constitutes the first-line standard of care procedure in high-risk newborns. However, no data is available in capillary blood on perinatal bias such as gestational age (GA), weight at birth (BW), delivery mode, and gender. The aims of the present study were to investigate whether in a cohort of healthy preterm (PT) and term (T) infants BPGA were GA, BW, delivery mode and gender dependent, thus affecting BPGA reliability as diagnostic test.</p><p><strong>Methods: </strong>We performed a prospective case-control study in 560 healthy infants (PT: n=115, T: n=445). BPGA was measured within 24-h from birth. Perinatal characteristics, outcomes, and clinical examination were also recorded.</p><p><strong>Results: </strong>PT infants showed higher (p<0.001) carbon dioxide partial pressure (pCO<sub>2</sub>), fraction of fetal hemoglobin (HbF), base excess (BE), bicarbonate (HCO<sub>3</sub>), and lower lactate (Lac) levels. When corrected for delivery mode, higher (p<0.001) HbF, BE, HCO<sub>3</sub>, and lower Lac levels were found. Similarly, higher (p<0.05, for all) pCO<sub>2</sub>, HbF, BE, HCO<sub>3</sub> and lower Lac levels were found between female and male PT and T infants. Repeated multiple logistic regression analysis showed that BPGA was GA, BW, delivery mode and gender dependent.</p><p><strong>Conclusions: </strong>The present results showing that BPGA can be affected by a series of perinatal outcomes open the way to further investigations providing longitudinal BPGA reference curves in the transitional phase, thus empowering BPGA role as a reliable diagnostic and therapeutic strategies efficacy marker.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142079494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of BCR::ABL1 p210 mRNA transcript quantification and ratio to ABL1 control gene converted to the International Scale by chip digital PCR and droplet digital PCR for monitoring patients with chronic myeloid leukemia. 通过芯片数字 PCR 和液滴数字 PCR 比较分析用于监测慢性髓性白血病患者的 BCR::ABL1 p210 mRNA 转录本定量及与 ABL1 对照基因的比率(按国际标度转换)。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-20 DOI: 10.1515/cclm-2024-0456
Wannachai Saisaard, Weerapat Owattanapanich
{"title":"Comparative analysis of BCR::ABL1 p210 mRNA transcript quantification and ratio to ABL1 control gene converted to the International Scale by chip digital PCR and droplet digital PCR for monitoring patients with chronic myeloid leukemia.","authors":"Wannachai Saisaard, Weerapat Owattanapanich","doi":"10.1515/cclm-2024-0456","DOIUrl":"https://doi.org/10.1515/cclm-2024-0456","url":null,"abstract":"<p><strong>Objectives: </strong>Chronic myeloid leukemia (CML) is characterized by the Philadelphia chromosome, leading to the <i>BCR::ABL1</i> fusion gene and hyper-proliferation of granulocytes. Tyrosine kinase inhibitors (TKIs) are effective, and minimal residual disease (MRD) monitoring is crucial. Digital PCR platforms offer increased precision compared to quantitative PCR but lack comparative studies.</p><p><strong>Methods: </strong>Eighty CML patient samples were analyzed in parallel using digital droplet PCR (ddPCR) (QXDx™ BCR-ABL %IS Kit) and chip digital PCR (cdPCR) (Dr. PCR™ BCR-ABL1 Major IS Detection Kit).</p><p><strong>Results: </strong>Overall, qualitative and quantitative agreement was good. Sensitivity analysis showed positive percentage agreement and negative percentage agreement were both ≥90 %, and the quadratic weighted kappa index for molecular response (MR) level categorization was 0.94 (95 %CI 0.89, 0.98). MR levels subgroup analysis showed perfect categorical agreement on MR level at MR3 or above, while 35.4 % (17/48) of patient samples with MR4 or below showed discordant categorizations. Overall, Lin's concordance correlation coefficient (CCC) for the ratio of %<i>BCR::ABL1</i>/<i>ABL1</i> converted to the International Scale (<i>BCR::ABL1</i> <sup>IS</sup>) was almost perfect quantitative agreement (Lin's CCC=0.99). By subgroups of MR levels, Lin's CCC showed a quantitative agreement of <i>BCR::ABL1</i> <sup>IS</sup> decreased as MR deepened.</p><p><strong>Conclusions: </strong>Both cdPCR and ddPCR demonstrated comparable performance in detecting <i>BCR::ABL1</i> transcripts with high concordance in MR3 level or above. Choosing between platforms may depend on cost, workflow, and sensitivity requirements.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C-terminal alpha-1-antitrypsin peptides as novel predictor of hospital mortality in critically ill COVID-19 patients. C端α-1-抗胰蛋白酶肽是预测COVID-19重症患者住院死亡率的新指标。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-19 DOI: 10.1515/cclm-2024-0920
Franziska Scherr, Daniel Schwarzkopf, Daniel Thomas-Rüddel, Michael Bauer, Michael Kiehntopf
{"title":"C-terminal alpha-1-antitrypsin peptides as novel predictor of hospital mortality in critically ill COVID-19 patients.","authors":"Franziska Scherr, Daniel Schwarzkopf, Daniel Thomas-Rüddel, Michael Bauer, Michael Kiehntopf","doi":"10.1515/cclm-2024-0920","DOIUrl":"https://doi.org/10.1515/cclm-2024-0920","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is sweat conductivity still a relevant screening test for cystic fibrosis? Participation over 10 years. 汗液电导率仍是囊性纤维化的相关筛查试验吗?参与时间超过 10 年。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-19 DOI: 10.1515/cclm-2024-0909
Natasha Robbins, R John Massie, Avis McWhinney, Natasha Heather, Lawrence Greed, Peter Graham, Samantha Shepherd, Trisha Andersen, Ronda F Greaves
{"title":"Is sweat conductivity still a relevant screening test for cystic fibrosis? Participation over 10 years.","authors":"Natasha Robbins, R John Massie, Avis McWhinney, Natasha Heather, Lawrence Greed, Peter Graham, Samantha Shepherd, Trisha Andersen, Ronda F Greaves","doi":"10.1515/cclm-2024-0909","DOIUrl":"https://doi.org/10.1515/cclm-2024-0909","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copeptin as a diagnostic and prognostic biomarker in pediatric diseases. 作为儿科疾病诊断和预后生物标志物的 Copeptin。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-19 DOI: 10.1515/cclm-2024-0839
Xiaoli Shu, Fengqing Cai, Wei Li, Hongqiang Shen
{"title":"Copeptin as a diagnostic and prognostic biomarker in pediatric diseases.","authors":"Xiaoli Shu, Fengqing Cai, Wei Li, Hongqiang Shen","doi":"10.1515/cclm-2024-0839","DOIUrl":"https://doi.org/10.1515/cclm-2024-0839","url":null,"abstract":"<p><p>Arginine vasopressin (AVP) plays a main role in maintaining the homeostasis of fluid balance and vascular tone and in regulating the endocrine stress response in response to osmotic, hemodynamic and stress stimuli. However, the difficulty in measuring AVP limits its clinical application. Copeptin, the C-terminal part of the AVP precursor, is released in an equimolar concentration mode with AVP from the pituitary but is more stable and simple to measure. Therefore, copeptin has emerged as a promising surrogate marker of AVP with excellent potential for the diagnosis, differentiation and prognosis of various diseases in recent decades. However, its application requires further validation, especially in the pediatric population. This review focuses on the clinical value of copeptin in different pediatric diseases and the prospects for its application as a potential biomarker.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical appraisal of the CLSI guideline EP09c "measurement procedure comparison and bias estimation using patient samples". 对 CLSI 准则 EP09c "使用患者样本进行测量程序比较和偏差估计 "的严格评估。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-19 DOI: 10.1515/cclm-2024-0595
Bruno Mario Cesana, Paolo Antonelli, Simona Ferraro
{"title":"Critical appraisal of the CLSI guideline EP09c \"measurement procedure comparison and bias estimation using patient samples\".","authors":"Bruno Mario Cesana, Paolo Antonelli, Simona Ferraro","doi":"10.1515/cclm-2024-0595","DOIUrl":"https://doi.org/10.1515/cclm-2024-0595","url":null,"abstract":"<p><strong>Background: </strong>In laboratory setting evaluating the agreement between two measurement methods is a very frequent practice. Unfortunately, the guidelines to refer to are not free from criticisms from a statistical methodological point of view. We reviewed the Clinical and Laboratory Standards Institute guideline EP09c, 3rd ed. pointing out some drawbacks and some aspects that have not been well defined, leaving situations of uncertainty and/or of excessive subjectivity in the judgement.</p><p><strong>Content: </strong>We have stressed the need of having replicates to estimate the systematic and the proportional biases of the measurement methods to be compared. Indeed, unequal variance of the two measurement methods gives a slope and intercept of the regression between the difference and the mean of the two values of the measurement methods to be compared that can be absolutely calculated from their means, their variances and their correlation coefficient. So, it is not possible to disentangle true from spurious biases. For laboratory professionals we have developed a worked exemplification of an agreement assessment.</p><p><strong>Summary: </strong>We have stressed the need of other approaches than the classic Bland and Altman method to calculate the systematic and proportional biases of two measurement methods compared for their agreement in a study with replicates.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor markers determination in malignant pleural effusion: pearls and pitfalls. 恶性胸腔积液的肿瘤标志物测定:珍珠与陷阱。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-16 DOI: 10.1515/cclm-2024-0542
Wen-Qi Zheng, José M Porcel, Zhi-De Hu
{"title":"Tumor markers determination in malignant pleural effusion: pearls and pitfalls.","authors":"Wen-Qi Zheng, José M Porcel, Zhi-De Hu","doi":"10.1515/cclm-2024-0542","DOIUrl":"https://doi.org/10.1515/cclm-2024-0542","url":null,"abstract":"<p><p>Serum and pleural fluid tumor markers are well-recognized auxiliary diagnostic tools for malignant pleural effusion (MPE). Here, we discuss some pearls and pitfalls regarding the role of tumor markers in MPE management. The following issues are discussed in this article: What is the appropriate clinical scenario for evaluating pleural tumor markers? Which tumor markers should be advocated for diagnosing MPE? Can extremely high levels of tumor markers be employed to establish a diagnosis of MPE? Does the serum-to-pleural fluid ratio of a tumor marker have the same diagnostic efficacy as the measurement of that marker alone in the pleural fluid? Can tumor markers be used to estimate the risk of specific cancers? What should be considered when interpreting the diagnostic accuracy of tumor markers? How should tumor marker studies be performed? We addressed these issues with published works, particularly systematic reviews and meta-analyses.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update. 针对 KP.2 和 KP.3 的中和抗体:当前疫苗需要更新的原因。
IF 3.8 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2024-08-16 DOI: 10.1515/cclm-2024-0919
Constant Gillot, Clara David, Jean-Michel Dogné, Julien Cabo, Jonathan Douxfils, Julien Favresse
{"title":"Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.","authors":"Constant Gillot, Clara David, Jean-Michel Dogné, Julien Cabo, Jonathan Douxfils, Julien Favresse","doi":"10.1515/cclm-2024-0919","DOIUrl":"https://doi.org/10.1515/cclm-2024-0919","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信